Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

613 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459).
Fastner G, Reitsamer R, Urbański B, Kopp P, Murawa D, Adamczyk B, Karzcewska A, Milecki P, Hager E, Reiland J, Ciabattoni A, Matuschek C, Budach W, Nowell K, Schumacher C, Ricke A, Fusco V, Vidali C, Alessandro M, Ivaldi GB, Ziegler I, Fussl C, Zehentmayr F, Grambozov B, Sir A, Hitzl W, Ricardi U, Sedlmayer F. Fastner G, et al. Among authors: kopp p. Radiother Oncol. 2020 May;146:136-142. doi: 10.1016/j.radonc.2020.02.001. Epub 2020 Mar 6. Radiother Oncol. 2020. PMID: 32151790 Clinical Trial.
IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Fastner G, Reitsamer R, Ziegler I, Zehentmayr F, Fussl C, Kopp P, Peintinger F, Greil R, Fischer T, Deutschmann H, Sedlmayer F. Fastner G, et al. Among authors: kopp p. Int J Cancer. 2015 Mar 1;136(5):1193-201. doi: 10.1002/ijc.29064. Epub 2014 Jul 10. Int J Cancer. 2015. PMID: 24995409
Intraoperative radiotherapy (IORT) as boost in breast cancer.
Sedlmayer F, Reitsamer R, Wenz F, Sperk E, Fussl C, Kaiser J, Ziegler I, Zehentmayr F, Deutschmann H, Kopp P, Fastner G. Sedlmayer F, et al. Among authors: kopp p. Radiat Oncol. 2017 Jan 19;12(1):23. doi: 10.1186/s13014-016-0749-9. Radiat Oncol. 2017. PMID: 28103903 Free PMC article. Review.
Boost IORT in Breast Cancer: Body of Evidence.
Sedlmayer F, Reitsamer R, Fussl C, Ziegler I, Zehentmayr F, Deutschmann H, Kopp P, Fastner G. Sedlmayer F, et al. Among authors: kopp p. Int J Breast Cancer. 2014;2014:472516. doi: 10.1155/2014/472516. Epub 2014 Sep 2. Int J Breast Cancer. 2014. PMID: 25258684 Free PMC article. Review.
Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment.
Bachmayer S, Fastner G, Vaszi A, Iglseder W, Kopp P, Holzinger J, Dinnewitzer A, Rinnerthaler G, Gampenrieder SP, Emmanuel K, Greil R, Sedlmayer F, Zehentmayr F. Bachmayer S, et al. Among authors: kopp p. Strahlenther Onkol. 2018 Jul;194(7):627-637. doi: 10.1007/s00066-018-1281-7. Epub 2018 Mar 1. Strahlenther Onkol. 2018. PMID: 29497791 Free PMC article.
613 results